首页 | 本学科首页   官方微博 | 高级检索  
相似文献
 共查询到20条相似文献,搜索用时 515 毫秒
1.
参考Genebank发表的伪狂犬病病毒(Pseudorabies Virus,PRV)的gI糖蛋白基因序列,自行设计合成一对引物,对PRV上海株(PRV-SH)进行PCR扩增,产物经琼脂糖电泳分析,呈现一条约960bp的条带,将其克隆入pGEM-T-easy载体中,并进行序列测定,与PRV Rice株gI基因比较发现,核苷酸的同源性为94.7%,氨基酸的同源性为91.3%,证实为gI基因。  相似文献   

2.
伪狂犬病病毒(pseudorabies virus, PRV)属于甲型疱疹病毒亚科水痘病毒属,其基因组约为150 kb,可分为独特长区、内部重复序列、独特短区以及末端重复序列。PRV US3基因位于其基因组的独特短区,属于复制非必须基因,是病毒的重要毒力基因,编码产物是丝/苏氨酸激酶。US3基因编码蛋白是一种多功能蛋白,可参与PRV逃避宿主免疫清除,抑制病毒介导的细胞凋亡,影响病毒粒子在细胞核质中的运输,调动感染细胞肌动蛋白骨架重排,诱导宿主细胞形态改变进而增强PRV在细胞中的传播能力,在病毒生命周期的多个阶段发挥作用。本文综述了PRV US3编码蛋白功能的研究进展,为PRV致病机制的研究提供了参考。  相似文献   

3.
猪伪狂犬病毒(Pseudorabies virus, PRV)为疱疹病毒科DNA病毒,可引起仔猪高热、神经症状和母猪繁殖障碍。PRV由于其传播途径多样、危害大的特点,给我国猪业养殖带造成了巨大损失。PRV的基因是其发挥生物学功能的基础,自2011年以来我国PRV不断出现变异,国外进口疫苗已不能起到很好的保护作用,这对PRV的防控形成了不小的挑战。论文对PRV的基因结构及主要基因功能进行了归纳总结,为PRV新疫苗及药物的研发提供理论参考。  相似文献   

4.
根据GenBank中公布的猪伪狂犬病病毒(pseudorabies virus,PRV)UL区基因序列(KJ789182)设计2对特异性引物,扩增PRV NY株TK基因两侧序列,克隆至pUC-19载体,然后绿色荧光蛋白标记基因,构建转移质粒pUC-TKLRE。用转移质粒pUC-TKLRE和PRV双基因缺失突变株rPRV NY-gE~-/gI~- DNA共转染ST细胞,通过蚀斑纯化,获得表达荧光蛋白的PRV三基因缺失突变株rPRV NY-gE~-/gI~-/TK~--EGFP~+。经PCR鉴定及测序,证实获得的三基因缺失株rPRV NY-gE~-/gI~-/TK~--EGFP~+在TK基因上缺失了311 bp。该病毒与亲本株PRV NY在ST细胞上培养时,具有相似的生长曲线,但其体外生长动力学比亲本株弱;且对非靶标动物小鼠是安全的。结果表明,本试验釆用同源重组,同时结合蚀斑克隆纯化技术,成功构建了1株以目前PRV流行变异株为亲本株的gE/gI/TK三基因缺失病毒,为防控当前PRV变异毒株的疫情、根除PR提供技术支持。  相似文献   

5.
本研究旨在获得重组伪狂犬病病毒(PRV)gE蛋白及其多克隆抗体。利用PCR方法从PRV感染猪的肺脏、脑和扁桃体混合组织中扩增PRV gE基因,连接至克隆载体pMD18-T(pMD-gE)后进行测序与进化树分析。以pMD-gE为模板,利用PCR方法扩增其膜外结构域部分基因(gE-outside),将其连接至原核表达载体pET-30a(+),转化大肠杆菌DH5α感受态细胞,构建重组质粒pET-gE-outside。将重组质粒pET-gE-outside转化大肠杆菌RosettaTM(DE3)pLysS感受态细胞,经IPTG诱导后,通过SDS-PAGE和Western blotting进行表达产物的分析与鉴定。经亲和层析技术纯化重组PRV gE蛋白并免疫小鼠,通过间接ELISA和Western blotting分别进行三免3周血清中鼠抗PRV gE多克隆抗体效价的测定和鉴定。PCR和测序结果表明,本研究成功克隆了PRV gE基因,与国内2011年以后流行毒株属于相同分支。SDS-PAGE和Western blotting结果证实,PRV gE-outside基因在原核表达系统获得正确表达,分子质量约为55 ku,且可与猪抗PRV多克隆抗体发生免疫反应。经亲和层析纯化的gE-outside蛋白浓度为1.23 mg/mL。将其免疫小鼠,三免3周的小鼠血清中鼠抗PRV gE-outside多克隆抗体效价为1:204 800,并可与gE-outside蛋白发生免疫反应。综上,本研究制备了重组PRV gE蛋白和鼠抗PRV gE蛋白多克隆抗体,可为PRV感染机制研究及建立快速、高效免疫学检测技术提供技术指导和材料。  相似文献   

6.
根据GenBank中已发表的猪伪狂犬病病毒(PRV) gE、gI基因的序列设计了2对引物,对PRV NP株的gE、gI基因进行了PCR扩增、回收、克隆、测序,测序结果与预期的PRV gE、gI基因片段相符。同源性比对分析结果显示,PRV NP株gE、gI基因推导的氨基酸序列与国内分离的PRV毒株的同源性分别为95.7%~99.8%、89.9%~99.5%。遗传进化树分析和氨基酸序列比对结果发现PRV NP株的gE氨基酸序列发生变化的位点与2012年国内分离到的PRV流行株相同,从而推测NP株为PRV变异毒株,本研究为PRV的流行病学调查分析奠定了基础,也为开发科学、有效的新型猪伪狂犬病(PR)疫苗提供科学依据。  相似文献   

7.
本研究利用CRISPR/Cas9基因编辑技术对本实验室分离得到的PRV GD株的gI和gE基因进行基因敲除,经蚀斑纯化结合PCR鉴定的方法获得gI和gE基因缺失毒株,命名为PRV GD-delgI/gE。试验测定了该基因缺失病毒在PK-15细胞中培养的一步生长曲线及其对小鼠的致病力。试验结果表明,与亲本毒株PRV GD株相比,PRV GD-delgI/gE在PK-15细胞中的繁殖能力有轻微降低,对小鼠的毒力明显降低,且该基因缺失病毒遗传稳定,可作为新型PRV疫苗的候选毒株,并为针对变异毒株的控制和新型疫苗的研制奠定了一定的基础。  相似文献   

8.
为了解广西野生动物伪狂犬病病毒(PRV)的感染状况,本研究采用ELISA方法对采集自广西境内的102份野生动物血清样品进行PRV g E和g B抗体检测,并对抗体阳性动物的组织样品进行PCR检测和PRV g E基因测序分析。ELISA结果显示血清样品中PRV抗体总阳性率为3.92%(4/102),野猪阳性率为11.76%(4/34),表明广西野猪群中存在PRV感染。PCR检测结果显示,4份血清阳性样品的动物组织中有2份呈PRV阳性,核苷酸序列分别命名为GXLL/2010和GXNP/2010,并对其进行PRV g E基因遗传进化分析,结果显示,GXLL/2010与PRV新流行株处于同一进化分支,GXNP/2010与PRV经典株处于同一进化分支,表明广西野猪群中可能同时存在不同PRV流行株。本研究结果为PRV的防控提供了实验依据。  相似文献   

9.
伪狂犬病病毒Guizhou-T1株的分离鉴定及其遗传变异研究   总被引:1,自引:0,他引:1  
为了解贵州猪伪狂犬病病毒(PRV)流行株的病原形态特征、致病性及遗传变异情况,本实验对收集自贵州规模化猪场伪狂犬病净化过程中PCR检测的阳性病料样品,采用细胞接毒分离培养、病毒的形态结构观察和易感动物接种试验对其病原进行鉴定。结果显示,本研究分离到一株PRV,命名为PRV Guizhou-T1株;并对其进行病毒效价的测定及g E基因核苷酸和氨基酸序列差异性分析。结果显示:PRV Guizhou-T1株gE基因序列与GZ-Z1株和Guizhou-DY株同源性分别为97.5%和99.3%,其TCID_(50)为10~(-10.11)/100μL;PRV Guizhou-T1株在gE基因编码的氨基酸序列第48和第496位均有天冬氨酸(Asp D)的插入,与PRV变异株变异位点一致,且在其第48位缺失酪氨酸(Tyr Y)。表明本研究分离得到了一株PRV变异株。本研究可为贵州PRV病原学的研究提供参考。  相似文献   

10.
为了解种猪场公猪感染伪狂犬病病毒(Pseudorabies Virus,PRV)野毒和精液中PRV散毒情况,自2016年10月至2018年3月,我们对河南省22家猪场的219头杜洛克公猪的血清进行了PRV野毒g E抗体检测,同时对这219头公猪相对应的219份杜洛克精液样本进行PRV-g E基因的聚合酶链式反应(Polymerase Chain Reaction,PCR)检测。结果显示:这22家猪场中有2家猪场的公猪PRV野毒g E抗体和精液中PRV-g E基因的PCR检测结果均为阴性;在20家PRV野毒g E抗体检测阳性的猪场中,PRV野毒感染率最低为44.44%,最高为100%;在22家猪场中,公猪PRV野毒平均感染率为79.45%,精液中通过PCR可检测到PRV野毒的平均比例为20.55%;在PRV野毒g E抗体检测结果为阳性的公猪中,25.86%的公猪可通过PCR方法检测证明其精液携带PRV的野毒。结果说明河南省受调查猪场公猪感染PRV比率较高,但PRV野毒g E抗体阳性的公猪通过PCR技术能在精液中检测到阳性的比率较低。  相似文献   

11.
In Japan, most pig populations are now free from pseudorabies virus (PRV) due to the recent success of an extensive eradication program. However, PRV infection persists in Japanese wild boars (Sus scrofa leucomystax), representing another potential reservoir for the virus in Japan. In this study, the seroprevalence of PRV in wild boars captured in three different prefectures was ascertained. A virus neutralization (VN) test showed that 6 of 173 serum samples (3%) were positive for VN antibody; glycoprotein E-ELISA revealed infection with the wild-type, but not the available vaccine strain, PRV. These results indicate that PRV has continued to spread among wild boars in Japan.  相似文献   

12.
The aim of this study was to investigate the effects of a porcine reproductive and respiratory syndrome virus (PRRSV) infection on the development of the immune response after pseudorabies virus (PRV) vaccination in pigs. Pigs were intranasally inoculated with the European PRRSV strain, Lelystad virus ter Huurne, and were vaccinated intramuscularly with PRV 2 weeks later (LV-PRV group). Control pigs were vaccinated with PRV only (PRV group). Eight weeks after PRV vaccination, pigs from both groups were challenged intranasally with wild-type PRV. We measured the lymphoproliferative, and the cytolytic responses to PRV of peripheral blood mononuclear cells (PBMC), isolated from blood samples. In addition, serum samples were examined for antibodies against PRV and LV. One week after PRV vaccination, PBMC proliferated abundantly to PRV in both groups. However, in the LV-PRV group the lymphoproliferative response declined after 1 week, whereas, in the PRV group, the lymphoproliferative response was high for 3 weeks and declined thereafter (P<0.05). After challenge, the lymphoproliferative response was 1 week earlier and was consistently and significantly higher in the PRV group than in the LV-PRV group. The PRV-specific killing was higher at 3 weeks after PRV vaccination and 5 weeks after PRV challenge 19+/-3 and 24+/-6%, respectively, in the PRV group, compared to 7+/-4 and 6+/-9%, respectively, in the LV-PRV group (P<0.05). However, later after vaccination and challenge the cytolytic response was identical in both groups. The antibody titre against PRV developed equally in both groups. After challenge, no PRV virus was isolated from both groups. From these results we conclude that, although PRRSV infection did cause changes in the time course of the T-lymphocyte response after PRV vaccination, PRRSV infection did not inhibit the development of vaccine-induced protection after PRV.  相似文献   

13.
《Veterinary microbiology》1997,54(2):113-122
Pseudorabies virus (PRV) vaccines are often compared for their capacity to reduce virus excretion after a challenge infection. Vaccines, used for the eradication of PRV, however, should reduce transmission of PRV among pigs. The purpose of this study was to investigate whether the amount of virus excreted after a challenge infection is an accurate measure of the capacity of a vaccine to reduce transmission of PRV among pigs. Two experiments were carried out, each using two groups of 10 pigs. The pigs in group one were intramuscularly vaccinated once with the glycoprotein E (gE)-negative vaccine X, the pigs in group two with the gE-negative strain 783. Eight weeks later, 5 pigs in each group were inoculated with wild-type PRV. A gE-ELISA was used to detect PRV infection. The transmission of PRV was estimated from the number of contact infections and expressed as the reproduction ratio R. The inoculated pigs vaccinated with vaccine X shed significantly more virus than the inoculated pigs vaccinated with strain 783. However, despite the difference in virus excretion, the transmission of PRV between the two groups did not differ. We conclude that virus excretion is not an accurate measure for determining vaccine effectiveness. However, R of vaccine X (R = 0.98) was not significantly below one, whereas R of vaccine 783 (R = 0) was significantly below one. Consequently, we cannot exclude the possibility that major outbreaks of PRV occur among pigs vaccinated with vaccine X.  相似文献   

14.
Subcutaneous injections of modified-live pseudorabies virus (PRV) vaccine into lambs caused clinical signs and death within 1 week after injection in 4 of 5 inoculated lambs. The clinical signs included depression, high fever, muscle fasciculations and convulsions, occasionally followed by death within 48 hours of the initial clinical signs. Histologic examinations and virus isolation procedures demonstrated PRV in the CNS of infected lambs. Sera from sick lambs remained negative for PRV antibodies. Two subsequent serial passages of the vaccine virus in lambs resulted in similar clinical signs and death in 6 of 10 inoculated lambs. Again, PRV was isolated from tissues of sick lambs, and the histopathologic findings were characteristic of the disease. Affected lambs remained seronegative to PRV, as did lambs that remained clinically normal after inoculation. There was no evidence of PRV transmission to uninoculated lambs and pigs housed with the infected lambs.  相似文献   

15.
本研究以伪狂犬病病毒(pseudorabies virus, PRV)Ra株体外感染ST细胞为生物模型,通过透射电镜对PRV的增殖规律和致细胞病变的显微结构进行观察。结果显示,PRV能诱导ST细胞发生明显病变,细胞的病变程度与PRV感染时间密切相关。PRV Ra株感染ST细胞,病毒吸附于ST细胞表面,以膜融合内陷的方式进入细胞和细胞核内,在细胞核内复制,出现包涵体结构,以出芽方式离开细胞核,在高尔基体等细胞内膜结构处完成病毒粒子的囊膜化过程。感染前期,病毒通过膜融合方式被释放到细胞外,完成细胞间病毒的传播;感染后期,细胞溶解,大量释放病毒粒子。感染细胞超微结构的变化主要体现为:线粒体肿胀、数目减少,嵴面积减少,核内出现包涵体,细胞融合,细胞内空泡化严重,溶细胞现象。  相似文献   

16.
17.
The influence of vaccine genotype and route of administration on the efficacy of pseudorabies virus (PRV) vaccines against virulent PRV challenge was evaluated in a controlled experiment using five genotypically distinct modified live vaccines (MLVs) for PRV. Several of these MLVs share deletions in specific genes, however, each has its deletion in a different locus within that gene. Pigs were vaccinated with each vaccine, either via the intramuscular or intranasal route, and subsequently challenged with a highly virulent PRV field strain. During a 2-week period following challenge with virulent PRV, each of the vaccine strains used in this study was evaluated for its effectiveness in the reduction of clinical signs, prevention of growth retardation and virulent virus shedding. One month after challenge, tissues were collected and analyzed for virulent PRV latency load by a recently developed method for the electrochemiluminescent quantitation of latent herpesvirus DNA in animal tissues after PCR amplification. It was determined that all vaccination protocols provided protection against clinical signs resulting from field virus challenge and reduced both field virus shedding and latency load after field virus challenge. Our results indicated that vaccine efficacy was significantly influenced by the modified live vaccine strain and route of administration. Compared to unvaccinated pigs, vaccination reduced field virus latency load in trigeminal ganglia, but significant differences were found between vaccines and routes of administration. We conclude that vaccine genotype plays a role in the effectiveness of PRV MLVs.  相似文献   

18.
Latency of pseudorabies virus (PRV) was established in 8 of 9 pigs born to 2 vaccinated sows. Pigs had high, low, or no maternal antibody titers at the time of the initial inoculation. At postinoculation months 3 to 4, latent PRV could be reactivated in vivo by the administration of large doses of corticosteroids. In most pigs, the stress-simulating treatment resulted in recrudescence of virus shedding after lag periods of 4 to 11 days. In 3 pigs, virus shedding was without clinical signs of disease, whereas clinical signs that developed in 4 pigs appeared to be due to the corticosteroid treatment, rather than to the reactivation of PRV. Pigs with a log10 neutralizing antibody titer of less than or equal to 2.55 at the onset of corticosteroid treatment had a booster response. Reactivated PRV spread to sentinel pigs housed with the inoculated pigs. Reactivation of PRV was also demonstrated in vitro. Explant cultures of trigeminal ganglia from pigs killed between postinoculation months 4 to 5 produced infectious virus. Restriction endonuclease analysis indicated that the reactivated PRV was indistinguishable from virus isolated shortly after the primary infection. Seemingly, pigs with maternal antibodies can become latently infected and therefore may be regarded as potential sources of dissemination of PRV.  相似文献   

19.
伪狂犬病弱毒株的分离鉴定及生物学特性的研究   总被引:3,自引:1,他引:2  
在流行病学调查中分离到1株病毒,经鉴定为伪狂犬病弱毒株,定名为F971株。分离病毒经克隆纯化后测得其毒价为10^7.59TCID50/ml,通过细胞中和试验表明分离病毒能也有效地被猪伪狂犬病毒闽A株阳性血清中和。病毒在电镜下可以清楚地观察到囊膜及外周纤突。分离株对3日龄乳鼠有一定的致病力,但对家兔、3日龄乳猪及妊娠母猪都有很高的安全性。用不同的剂量10^0、10^-1、10^-2肌肉注射3日龄乳猪后14天用10^5.7TCID50伪狂犬病强毒攻击,所有试验仔猪均得到保护。用分离株免疫母猪,其后代可获高滴度的母源抗体,15日龄的仔猪能抵御10^5.7TCID50强毒的攻击。用ELISA普查试剂盒测定免疫猪抗体,结果均为阳性,而用g^1-ELISA试剂盒测定抗体时,结果均为阴性。证明分离株具有缺损g^1糖蛋白的特性。综合上述特性,确定F971为1株g^1糖蛋白缺损的猪伪狂犬病弱毒株。  相似文献   

20.
从送检的2日龄病猪脑部分离到1株病毒。该病毒接种的Balb/c小鼠出现了典型的伪狂犬病症状,接种BHK-21细胞48h后出现了圆缩、集聚,脱落等典型的细胞病变,猪狂犬病毒阳性血清能特异性的中和该分离病毒。根据GenBank公布的PRV的gE基因设计的引物能扩增出特异性片段,证实该病毒为伪狂犬病毒。  相似文献   

设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号